| XEN445 |
(S)-2-(3-(PYRIDIN-2-YLMETHOXY)PYRROLIDIN-1-YL)-5-(TRIFLUOROMETHYL)BENZOIC ACID. HCL |
1515856-92-4 |
| UNC2025 |
反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-环己醇 |
1429881-91-3 |
| JNK-IN-8 |
JNK-IN-8 |
1410880-22-6 |
| Tazemetostat (EPZ-6438) |
EPZ-6438 |
1403254-99-8 |
| 1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
EPZ005687 |
1396772-26-1 |
| LDK-378 dihydrochloride |
双盐酸盐色瑞替尼 |
1380575-43-8 |
| LEE011 (succinate) |
LEE011 琥珀酸盐 |
1374639-75-4 |
| CO-1686 |
CO1686 |
1374640-70-6 |
| BRD4770 |
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯 |
1374601-40-7 |
| N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-Methyl-1H-iMidazol-1-yl)acetaMido)-2-(o-tolyl)acetaMide |
AGI-5198 (IDH-C35) |
1355326-35-0 |
| MK5172 |
格佐匹韦 |
1350514-68-9 |
| S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide |
GSK126 |
1346574-57-9 |
| E6446 (dihydrochloride) |
CS-2089 |
1345675-25-3 |
| INCB8761(PF-4136309) |
INCB8761(PF-4136309) |
1341224-83-6 |
| PI3K/HDAC Inhibitor |
CUDC-907 |
1339928-25-4 |
| Tubastatin A hydrochloride |
Tubastatin A盐酸盐 |
1310693-92-5 |
| GDC-0032 |
GDC 0032 |
1282512-48-4 |
| LY 2874455 |
LY2874455 |
1254473-64-7 |
| LGK-974 |
2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-联吡啶]-5-乙酰胺 |
1243244-14-5 |
| LRRK2-IN-1 |
5,11-二氢-2-[[2-甲氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 |
1234480-84-2 |
